Last reviewed · How we verify

NCT04438616

Comparison of Patient Satisfaction and Primary Implant Stability Between Two Different Magnetic Attachment

Status unknown NA Last updated 19 June 2020
What this trial tests

NA trial testing dome magnetic attachment in Edentulous Alveolar Ridge in 28 participants. Status unknown.

Timeline
1 September 2020
Primary endpoint
30 January 2021
30 April 2021

Quick facts

Lead sponsorCairo University
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposeother
Enrollment28
Start date1 September 2020
Primary completion30 January 2021
Estimated completion30 April 2021

Drugs / interventions tested

Conditions studied

Sponsor

Cairo University

Who can join

Adults 40 to 70, any sex, with Edentulous Alveolar Ridge. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

* Patients were randomly divided in to two groups by using computerized software ; the first group received flat magnetic attachment design while the second group received dome magnetic attachment design.which the inclusion criteria is completely edentulous patient ,Age range from 40 to 70 year old ,skeletal class 1, both sexes * Implant stability will be measured for both groups using smart peg /osstell at the day of implant installation and after 2,4,8,12 weeks. * Patient satisfaction measure in 2 weak and after 12 weak by Denture satisfaction questionnaire

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Edentulous Alveolar Ridge

Currently open trials in the same condition.

Other Cairo University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04438616.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing